Yubo International Biotech Limited (YBGJ)
OTCMKTS · Delayed Price · Currency is USD
0.0084
0.00 (0.00%)
Jun 1, 2026, 4:00 PM EST

YBGJ Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
124361149
Market Cap Growth
-94.38%-49.10%-88.45%215.79%-76.90%-
Enterprise Value
345361352
Last Close Price
0.010.010.030.300.100.42
PS Ratio
115.89171.071196.5559.45109.1639.60
PB Ratio
-0.62-1.09-1.26-19.50-20.13-375.59
EV/Sales Ratio
238.25287.011450.9160.25129.4341.43
Debt / Equity Ratio
-0.63-0.78-1.02-0.21-1.40-20.53
Net Debt / Equity Ratio
-0.63-0.77-1.02-0.21-1.37-20.32
Net Debt / EBITDA Ratio
-1.72-1.49-1.87-0.38-0.66-1.75
Net Debt / FCF Ratio
-2.24-1.78-2.51-0.52-1.28-1.68
Asset Turnover
0.010.010.000.300.030.35
Inventory Turnover
0.140.141.690.690.213.66
Quick Ratio
0.140.160.100.110.140.21
Current Ratio
0.200.240.140.210.300.38
Return on Equity (ROE)
------297.65%
Return on Assets (ROA)
-67.26%-62.33%-77.36%-37.19%-21.72%-27.43%
Return on Capital Employed (ROCE)
43.70%61.10%62.20%69.10%689.00%-85.80%
Earnings Yield
-64.00%-51.07%-42.76%-3.33%-10.59%-3.13%
FCF Yield
-45.53%-39.88%-32.22%-2.06%-5.28%-3.22%
Buyback Yield / Dilution
-3.76%-16.55%-900.00%89.91%-0.50%-1.94%